Jean‐Marie Grouin
Université de Rouen Normandie · 74 works · 2,019 citations · h-index 24
Top works
- Validation of an algofunctional index for osteoarthritis of the hand.
- Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: A prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect
- BAYESIAN PREDICTIVE APPROACH FOR INFERENCE ABOUT PROPORTIONS
- Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid:
- The average Adjusted Symptom Score, a new primary efficacy end‐point for specific allergen immunotherapy trials
- Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial
- Long‐term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes ( TIMES 2): A 52‐week, open‐label, multicentre phase 3 trial
- Adjustment for baseline covariates: an introductory note
- Subgroup Analyses in Randomized Clinical Trials: Statistical and Regulatory Issues
- Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes: A 24‐week, randomized, double‐blind, placebo‐controlled, dose‐ranging phase 2b trial
- Randomised, controlled trial of avocado–soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study
- Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial
- Early and systematic administration of fibrinogen concentrate in postpartum haemorrhage following vaginal delivery: the FIDEL randomised controlled trial
- Evaluation of PXL065 – deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1)
- Comparison of the Distribution of IgG and IgA Antibodies in Serum and Various Mucosal Fluids of HIV Type 1-Infected Subjects
- Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study
- Fibrinogen concentrate as a treatment for postpartum haemorrhage-induced coagulopathy: A study protocol for a randomised multicentre controlled trial. The fibrinogen in haemorrhage of DELivery (FIDEL) trial
- IgG Subclass Distribution in Serum and Various Mucosal Fluids of HIV Type 1-Infected Subjects
- Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial
- Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients